Drug Type Small molecule drug |
Synonyms TCH-1116 |
Target |
Action inhibitors |
Mechanism PKC inhibitors(Protein kinase C inhibitors), Signal transduction pathway inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | China | 01 May 2012 |





